Abhijit Date, Ph.D., M.Pharm.Sc. is an Assistant Professor of Pharmaceutical Sciences at the Pharmaceutics andPharmacokinetics track and the Director of the Drug Pre formulation, Repurposing and Delivery (D-PReD) research laboratory at the Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University of Arizona.He is a drug delivery scientist by training with vast experience in the development and pre-clinical evaluation of conventional and novel drug delivery systems including nano medicines. He is listed as an inventor on 4 US patents or patent applications. He has more than 60 peer-reviewed publications and 4 book chapters to his credit. He serves as the Topic Editor for International Journal of Molecular Sciences and editorial board member of Current Nutraceuticals.
I am drug delivery scientist by training and my research is focused on the drug repurposing and reformulation for the improved therapy of acute myeloid leukemia, melanoma and non-melanoma skin cancers and early-stage bladder cancer. More specifically, we are interested in repurposing and reformulation of anthelmintic benzimidazoles and antidiabetic biguanides for the treatment of acute myeloid leukemia, early-stage bladder cancer and skin cancers.Currently, I collaborate with Penn State Cancer Institute and UVA Cancer Center for developing new therapies for acute myeloid leukemia. However, I would like to establish collaborations within the UACC for AML therapies. I just received a seed grant from UACC Skin Cancer Institute to develop novel phenformin nano formulations for the treatment of melanoma. I will be collaborating with Dr. Wondrak, Dr. Dickinson and Dr. Curiel to develop new therapies for the treatment of melanoma and non-melanoma skin cancers.